KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Arcosa (ACA) EBITDA (2017 - 2025)

Arcosa's EBITDA history spans 9 years, with the latest figure at $79.0 million for Q4 2025.

  • For Q4 2025, EBITDA rose 82.87% year-over-year to $79.0 million; the TTM value through Dec 2025 reached $341.9 million, up 73.03%, while the annual FY2025 figure was $341.9 million, 73.03% up from the prior year.
  • EBITDA for Q4 2025 was $79.0 million at Arcosa, down from $112.3 million in the prior quarter.
  • Across five years, EBITDA topped out at $208.1 million in Q4 2022 and bottomed at $15.6 million in Q4 2021.
  • The 5-year median for EBITDA is $50.0 million (2022), against an average of $58.6 million.
  • The largest annual shift saw EBITDA surged 1233.97% in 2022 before it tumbled 79.43% in 2023.
  • A 5-year view of EBITDA shows it stood at $15.6 million in 2021, then soared by 1233.97% to $208.1 million in 2022, then tumbled by 79.43% to $42.8 million in 2023, then rose by 0.93% to $43.2 million in 2024, then soared by 82.87% to $79.0 million in 2025.
  • Per Business Quant, the three most recent readings for ACA's EBITDA are $79.0 million (Q4 2025), $112.3 million (Q3 2025), and $94.8 million (Q2 2025).